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Tissue Engineering of Vascular Grafts: Human Cell Seeding of
Decellularised Porcine Matrix
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Objectives: to develop a biocompatible and mechanically stable vascular graft combining human cells and a xenogenic
acellular matrix.
Design/Materials: decellularised matrix tubes were obtained by enzymatic cell extraction of native porcine aortas.
Endothelial cells and myofibroblasts were isolated from human saphenous veins and grown in cell cultures. The inner
surface of the tubes was seeded with endothelial cells or myofibroblasts and exposed to pulsatile flow.
Results: after cell extraction, the absence of cellular components, as well as the maintenance of matrix integrity, was
demonstrated by means of light microscopy and scanning electron microscopy. Furthermore, the porcine matrix was
successfully seeded with human endothelial cells, which grew to a monolayer under flow conditions. Stable biomechanical
properties were achieved at physiological perfusion pressures in vitro.
Conclusions: cellular components can be extracted from native porcine blood vessels. Vascular grafts can be generated
in vitro of animal acellular matrix and human cells.
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prosthesis.
Introduction with a young patient.5–7 The aim of this study was
to develop a biocompatible and mechanically stable
Large-diameter (>5 mm internal diameter) vascular vascular graft combining human cells and a xenogenic
acellular matrix by means of tissue-engineering tech-grafts have been successfully developed from poly-
mers such as Dacron or expanded polytetra- niques.
fluoroethylene. However, it has been difficult to
develop grafts smaller than 5 mm internal diameter
because of biological reactions at the blood–material Materials and Methods
and tissue–material interface.1–4 Autologous vein grafts
require that a vein be removed from another part of Preparation of decellularised carotid arteries
the patient, if available. On the other hand, synthetic
grafts pose long-term health risks, and are not suc- Thoracic aortas of adult large German pigs (Pie´train
race) weighing 100–120 kg were obtained from a localcessful for small-diameter graft applications.
Engineering of vascular grafts by transplanting slaughterhouse. They were immediately stored in
Hanks’ balanced salt solution (HBSS, Biochrom, Berlin,autologous cells on specially designed scaffolds rep-
resents a new experimental concept to alleviate the Germany) at 4 °C. Warm ischaemia time was less than
10 min. After arriving at the laboratory (within 30 min),disadvantages of autografts, allografts, non-living
xenografts or prostheses. These disadvantages include the aortas were placed in a solution of 0.1% trypsin
(Biochrom) with 0.02% EDTA (Sigma) in phosphate-thromboembolism and thrombosis, anticoagulant-
related haemorrhage, neointima hyperplasia, and an- buffered saline (PBS) without Ca2+ and Mg2+ (solution
1) for 24 h. This procedure was followed by an in-eurysm formation, as well as the inability to grow
cubation with ribonuclease (RNase) A (20 lg/ml)
(Boehringer Mannheim, Germany) and desoxy-
* Please address all correspondence to: O. E. Teebken, Department ribonuclease (DNase) (0.2 mg/ml) (Boehringer Mann-of Thoracic and Cardiovascular Surgery, Hannover Medical School,
D-30623 Hannover, Germany. heim) for 2 h, and another incubation in solution 1 for
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24 h. All steps were conducted in a 5% CO2/95% air PBS without Ca2+ and Mg2+. Afterwards, they were
washed with M-199 containing 10% FBS to inactivateatmosphere at 37 °C under continuous shaking. Vessels
were washed with phosphate-buffered saline (PBS, residual trypsin. Cells were resuspended in culture
medium and subcultivated in 175-cm2 culture flasks.Biochrom, Germany) several times to remove residual
substances and were then stored in HBSS at 4 °C prior Endothelial cells from the second or third passage and
myofibroblasts from the third or fourth passage wereto further processing. Samples of the aortic wall were
taken before and after enzymatic treatment. used for seeding procedures.
Cell seeding and perfusion
Cell separation and expansion
For seeding procedures endothelial cells and myo-
Usually discarded segments of the greater saphenous fibroblasts were trypsinised, centrifuged and washed.
vein of patients undergoing coronary artery bypass They were resuspended in culture medium and an
surgery were stored in heparinised blood at 4 °C. aliquot was obtained for cell counting in a haemo-
Endothelial cells were harvested under sterile con- cytometer (Fuchs-Rosenthal, Germany) to adjust a
ditions as described previously.8 After rinsing with seeding density of approximately 120 000 cells/cm2. A
HBSS the segments were filled with 0.2% collagenase segment (5 cm) of the descending aorta was clamped
A (Boehringer Mannheim) in PBS with Ca2+ and Mg2+. at both ends, after ligating the intercostal arteries and
With both ends occluded the vessel was placed in a filled with cell suspension. After 60 min of incubation
Petri dish filled with HBSS and incubated in a 5% CO2/ (5% CO2/95% air atmosphere at 37 °C) the vessels were
95% air atmosphere at 37 °C for 20 min. Afterwards the gently rinsed with culture medium and a specimen for
vein was flushed with 50-ml M-199 medium with histological and electron microscopic studies of cell
L-glutamine (Biochrom) containing 10% fetal bovine attachment was taken.
serum (FBS, Life Technologies, Germany). The endo- For evaluation of retention and proliferation of
thelial cells were pelleted by centrifugation for 5 min seeded endothelial cells on the acellular matrix, the
at 300 g, followed by resuspension in 5 ml culture aortas were integrated in a custom-made bioreactor.
medium consisting of M-199, 10% pooled human Pulsatile flow was provided in the closed, sterile sys-
serum (Department of Haematology, Hannover Med- tem consisting of a perfusion chamber, a roller pump
ical School), 100 U/ml penicillin (Sigma, St Louis, MO, (Jostra, Hirrlingen, Germany), a paediatric cardiotomy
U.S.A.), 50 lg endothelial-cell growth factor (Boehr- reservoir (Sorin Biomedica, Salluggia, Italy) and ex-
inger Mannheim), and 5000 U/ml preservative-free tracorporal perfusion tubing (Jostra).9 The whole cir-
heparin (Heparin Novo, Nordisk, Mainz, Germany). cuit was filled with culture medium and placed in an
Finally they were placed in a 75 cm2 culture flask incubator. To simulate physiological flow rates in
(Corning Costar Corporation, Cambridge, MA, aortic roots, pressure was adjusted to 100 mmHg
U.S.A.), precoated with fibronectin (Sigma) with a (70–140 mmHg). The resulting flow was 120–190 ml/
resulting density of 10 000 cells/cm2. min. Samples for histology and scanning electron
The remaining vein segment was minced into 1-mm microscopy were taken after 120 min and 4 days of
pieces after removal of the adventitial tissue. They perfusion.
were incubated with 0.2% collagenase A (Boehringer Porcine aortas were decellularised and consecutively
Mannheim) and 0.1% elastase (Boehringer Mannheim) seeded with human endothelial cells (n=4) or myo-
in M-199 without growth factors for 120 min at 37 °C fibroblasts (n=4). Seeded aortas were inserted into a
in a humidified 5% CO2/95% air atmosphere. The perfusion circuit to evaluate cell retention and pro-
resulting suspension was centrifuged at 800 g for 5 min liferation.
and resuspended in 5-ml smooth-muscle-cell basal
medium (SmBM, Clonetics, U.S.A.) containing smooth-
muscle-cell growth medium 2 (SmGM 2, Clonetics). Microscopy
Cells were seeded (density 10 000 cells/cm2) onto
75 cm2 culture flasks (Corning Costar) and incubated For scanning electron microscopy the specimens were
fixed by immersion with glutaraldehyde (2.5%, inat 37 °C in 5% CO2 and 95% air. For culture of endo-
thelial cells and myofibroblasts, the medium was 0.1 M/l cacodylate buffer, pH 7.4) for 4 h immediately
after removal of the culture medium. All specimenschanged every 2nd or 3rd day. Just before monolayers
were grown to confluency, the cells were detached with were post-fixed with 2% osmium tetroxide in the same
buffer for 2 h, dehydrated in graded alcohol solutions,0.05% trypsin (Biochrom) and 0.02% EDTA (Sigma) in
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and critical-point dried over CO2. They were made
conductive by progressive osmium impregnation in a
vacuum evaporator (Ion Tech Ltd, Teddington, U.K.)
according to the method of Kelley et al. and examined
in a Phillips 505 microscope (XL29, 25 kV, Kassel,
Germany).10
Samples for light microscopy were stored in liquid
nitrogen. Semi-thin sections were stained with haemat-
oxylin–eosin with or without alcoholic saffron. Sec-
tions were subjected to an elastin stain or to Alcian
blue at pH 2.5 for proteoglycans.
In cell cultures endothelial cells and myofibroblasts
were identified by their typical morphological features.
Fresh samples of the aortic wall were taken 120 min
after endothelial cell seeding and washed several times Fig. 1. Scanning electron micrograph of a decellularised porcine
aorta 60 min after seeding with human endothelial cells. Note thewith PBS. They were incubated with two fluorescent
attached and round cells and the collagen fibres. Magnificationdyes, ethidium homodimer-1 (EthD-1) and calcein AM 1 ·1000.
(Molecular Probes, Eugene, OR, U.S.A.), at room tem-
perature to distinguish live and dead cells, sim-
with trypsin, DNase, and RNase, no cell nuclei orultaneously.14 Sections were counterstained with
intracellular components could be shown in theMeyer’s haematoxylin. Optical filters were purchased
haematoxylin–eosin cross-sections of the aortic wall.from Molecular Probes.
Immunohistochemical stains for endothelial cells (fac-
tor-VIII-related antigen, CD-31), myofibroblasts (alpha
Immunohistochemistry actin), and alpha-galactosyl epitopes were negative.
The endothelial cell layer was completely removed,
Endothelial cells were characterised by immuno- and the extracellular matrix fibres with openings of
histochemical staining (avidin–biotin–peroxidase tech- 1–10 lm were observed in scanning electron mi-
nique) of cyto-spins or frozen sections for the presence crographs. The remaining extracellular matrix con-
of factor VIII-related antigen (DAKO, Hamburg, Ger- sisted of collagen and elastin fibres from the original
many) or CD-31 integrin (DAKO) as described pre- vessel.
viously.11 The CD-31 antigen is exclusively presented Seeding density was 121 000–24 000 cells/cm2.
by human cells and therefore effective to distinguish Microscopic examination 60 min after static seeding of
them from porcine cells.12 Staining for alpha-galactosyl the acellular matrix demonstrated factor-VIII- and CD-
epitope was conducted with a biotinylated lectin from 31-positive endothelial cells on the surface of the aortic
Griffonia simplicifolia I B4 (Vector Laboratories, Bur- wall. Fluorescent staining with EthD-1 and calcein AM
lingame, CA, U.S.A.).13 Antibodies for actin-staining indicated attached and viable endothelial cells on the
to mark myofibroblasts, for collagen IV (DAKO) and aortic surface. Scanning electron microscopy showed
for laminin were purchased from Sigma. round endothelial cells on the graft surface (Fig. 1).
Negative control sections were treated with PBS Myofibroblasts behaved in a similar pattern. There
only and/or with appropriate normal isotopic IgG was no penetration of any cell type into the acellular
(DAKO). Positive controls consisted of untreated matrix at this point of time.
human saphenous veins (endothelial cells, myo- Aortas were macroscopically intact and remained
fibroblasts, collagen) and porcine aortae (alpha- mechanically stable in the mock circulation. After 2 h
galactosyl epitope). A goat anti-mouse antibody of perfusion using culture medium, the cells were still
(DAKO) served as a secondary antibody. Streptavidin– attached to the luminal surface of the aortic wall; both
peroxidase conjugate was then applied. Final staining round and polygonal flat cells were found. Following
was done with diaminobenzidine (DAKO). 4 days of perfusion in the bioreactor, the endothelial
cells had spread and divided on the graft surface.
This led to an almost complete coverage of the aorticResults
luminal surface, with an endothelial monolayer and a
partial endothelialisation (Fig. 2). On the other hand,Fresh porcine aorta showed the typical features of this
vessel. Particularly, the endothelial cell lining of all myofibroblasts showed a tendency to build more than
one cell layer (Fig. 3).specimens remained intact. After enzymatic treatment
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Fig. 2. Spread endothelial cells building a confluent monolayer on
the inner surface of an acellularised matrix tube after 4 days in
the bioreactor. Haematoxylin–eosin stain of a representative area.
Magnification 1 ·150.
Discussion Fig. 3. Myofibroblasts on the luminal surface of the graft building
more than one cell layer were seen in one single case. Generally
they were arranged as monolayers. Haematoxylin–eosin stain. Mag-We have developed a multi-step enzymatic extraction
nification 1 ·150.
method, involving the natural enzymes trypsin,
DNase, and RNase. This procedure is capable of re-
moving cell components as well as cellular antigens, which supplies the structure and the stability of the
tissue-engineered vessel. Due to the non-existence oflipids, and to some extent soluble glycosaminoglycans
from porcine aortic tissue. The remaining extracellular cellular antigens, especially foreign endothelial-cell
antigens, the immunological potential of the resultingmatrix consists of well-conserved and normally ar-
ranged collagen and elastin fibres. These structural structure seems very low. Furthermore, the remaining
matrix fibres, collagen and elastin (and proteoglycans,proteins provide an acellular scaffold, which can be
successfully seeded with human venous endothelial structural glycoproteins), exhibit a great homology
between man and swine. These features may preventcells, subsequently. In a perfusion circuit under high-
pressure conditions, the cells form a monolayer on the graft from critical inflammatory or immune re-
actions.the luminal surface but do not invade the matrix.
Furthermore, instead of penetrating the matrix, myo- Unlike other extraction methods, for example using
detergents, which disturb endothelialisation of graftsfibroblasts in some cases accumulated at the inner
surface. In a clinical setting, this unfavourable be- both in vivo and in vitro, we used biological enzymes
with a limited toxicity.5 To illustrate this, the action ofhaviour may lead to graft stenosis. Interestingly, this
problem did not arise in another study after im- trypsin is antagonised in the presence of serum. This
may be a favourable element at the time of cell-seedingplantation in an allogenous pig model (unpublished
data). and additionally at the time of implantation (blood
contact with the matrix) to reduce a systemic reactionThe centre of our concept is the acellular matrix,
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on the graft. Many ideas in tissue engineering are integration and provide a truly stable artifical blood
vessel. In the future, we have to enable the acellularbased on (biodegradable) synthetic scaffolds. These
matrix grafts gradually to become transformed frommaterials can induce foreign-body reaction, especially
a xenograft to an implant of primarily autogenous,if they are not completely degraded at the time of
self-renewing and living tissue. This requires the in-implantation, or they can also be substantially throm-
tegration of smooth-muscle cells and fibroblasts intobogenic.15 The extracellular matrix is a complex
the acellular matrix scaffold, either in vivo via theordered aggregate composed of a number of different
adjacent tissue after implantation or in vitro by meansmacromolecules whose structural integrity and func-
of cultivated cells. The resulting prosthesis is derivedtional composition are important in maintaining nor-
from natural arteries and would have several distinctmal tissue architecture, in development, and in tissue
theoretical advantages like the similar mechanicalfunction.16 The role of collagen and other structural
properties, the syngenous origin, and the potentialmacromolecules in the aortic wall and their interaction
ability to remodel or grow. As shown in Figure 3,in regarding mechanical properties was investigated
myofibroblasts do not penetrate the matrix after havingby Scott et al.17 From our light- and scanning-electron-
been seeded on the inner surface. Surface modificationmicroscopic experience there is evidence that the ar-
with chemotactic factors may overcome this problemchitecture of fibres is maintained after enzyme treat-
in the future. Furthermore, it must be shown thatment with trypsin, DNase, and RNase. Final
the acellular matrix graft will not elicit a substantialconclusions about an intact microstructure of the acel-
inflammatory reaction that could either damage thelular matrix can be made after mechanical testing
graft wall (especially the elastic lamellae), setting theand definitely after transmission-electron-microscopic
scene for long-term aneurysm formation, or triggerexamination and comparison with the intact vessel.
acute thrombosis. Furthermore, we must show long-Preserved matrix integrity plays a major role for cell
term durability with freedom from both calcificationmetabolism,18 function,19 interaction,20 and adhesion.
and excessive tissue overgrowth in an endothelialCell attachment can be significantly improved by in-
cell-seeded allograft/xenograft after implantation incubation with peptides containing the RGD sequence,
animals.which is present in different matrix proteins, for ex-
ample vitronectin.21 This is of great importance, since at
present no sufficiently abundant source of endothelial
cells exists in humans to provide reliable confluent Acknowledgement
coverage of a prosthetic graft. Current methods of
We are grateful to Bettina Giere and Tanja Herden for their excellentharvesting are relatively inconsistent and empirical
technical assistance and to the Deutsche Forschungsgemeinschaftand therefore many clinical studies have taken place for providing funding to this project.
against a background of poorly-defined experimental
techniques.22 Nevertheless, endothelialisation is one of
the most promising mechanisms to reduce throm-
Referencesbogenicity of any cardiovascular implant,23,24 but fails
to attenuate intimal thickening in vascular prostheses.25
1 Langer R, Vancanti JP. Tissue engineering. Science 1993; 260:Vascular grafts in humans do not spontaneously form 920–926.
an endothelial monolayer, which may contribute to 2 Campbell CD, Goldfarb D, Roe R. A small arterial substitute:
expanded microporous polytetrafluoroethylene: patency versusgraft failure.26 This pattern demonstrates the import-
porosity. Ann Surg 1975; 182: 138–143.ance of other factors involved in the development of 3 DeBakey ME, Jordan GL, Abbott JP, O’Neal RM. The fate of
dacron vascular grafts. Arch Surg 1964; 89: 757–782.tissue-engineered blood vessels like cell–cell inter-
4 Molina JE, Carr M, Yarnoz MD. Coronary bypass with gore-actions, growth factors, flow conditions, shear stress,
tex graft. J Thorac Cardiovasc Surg 1978; 75: 769–771.
and combinations of any.27–30 With these issues in mind, 5 Wilson GJ, Yeger H, Klement P, Lee JM, Courtman DW.
Acellular matrix allograft small caliber vascular prostheses. AS-we used a bioreactor to mimic in vivo conditions in
IAO Transactions 1990; 36: M340–M343.order to maintain virtually complete endothelialisation 6 Dale WA, Lewis MR. Modified bovine heterografts for arterial
before potential implantation. The shear stress pro- replacement. Ann Surg 1969; 169: 927–946.
7 Mohr LL, Smith LL. Polytetrafluoroethylene graft aneurysms.vided by the perfusion technique allows cells to change
Arch Surg 1980; 115: 1467–1470.their morphology from round to flat and get their 8 Bader A, Schilling T, Teebken OE et al. Tissue engineering of
normal in vivo appearance. heart valves – human endothelial cell seeding of detergent
acellularized porcine valves. Eur J Cardiothorac Surg 1998; 14:This model of a tissue-engineered vascular graft has
279–284.many characteristics of a normal blood vessel. The 9 Walluscheck KP, Steinhoff G, Haverich A. Endothelial cell
seeding of de-endothelialised human arteries: improvement byabsence of synthetic material may allow complete graft
Eur J Vasc Endovasc Surg Vol 19, April 2000
O. E. Teebken et al.386
adhesion molecule induction and flow-seeding technology. Eur 21 Walluscheck KP, Steinhoff G, Haverich A. Endothelial cell
J Vasc Endovasc Surg 1996; 12: 46–53. seeding of native vascular surfaces. Eur J Vasc Endovasc Surg
10 Kelley RO, Decker RAF, Bluemink JG. Ligand-mediated os- 1996; 11: 290–303.
mium binding: its application in coating biological specimens 22 Mosquera DA, Goldman M. Endothelial cell seeding. Br J Surg
for scanning electron microscopy. J Ultrastrict Res 1973; 45: 1991; 78: 656–660.
254–258. 23 Schneider PA, Hanson SR, Price TM, Harker LA. Confluent
11 Hsu SM, Raine L. Protein A, avidin and biotin in immuno- durable endothelialization of endarterectomized baboon aorta
histochemistry. J Histochem Cytochem 1981; 29: 1349–1353. by early attachment of cultured endothelial cells. J Vasc Surg
12 Yan HC, Baldwin HS, Sun J et al. Alternative splicing of a 1990; 11: 365–372.
specific cytoplasmic exon alters the binding characteristics of 24 Lehner G, Fischlein T, Baretton G, Murphy JG, Reichart B.
murine platelet/endothelial cell adhesion molecule-1 (PECAM- Endothelialized heart valve prostheses in the non-human primate
1). J Biol Chem 1995; 270: 23672–23680. model. Eur J Cardiothorac Surg 1997; 11: 498–504.
13 LaVeccio JA, Dunne AD, Edge ASB. Enzymatic removal of 25 Conte MS, Choudhry RP, Shirakowa M, Fallon JT, Birinyi
alpha-galactosyl epitopes from porcine endothelial cells di- LK. Endothelial cell seeding fails to attenuate intimal thickening
minishes the cytotoxic effect of natural antibodies. Transplantation in balloon-injured rabbit arteries. J Vasc Surg 1995; 21: 413–421.
1995; 60: 841–847. 26 Williams SK, Jarrell BE. Tissue engineered vascular grafts.
14 Massia SP, Hubbell JA. Immobilized amines and basic amino Nature Medicine 1996; 2: 32–34.
acids as mimetic heparin-binding domains for cell surface pro- 27 Sterpetti AV, Cucina A, D’Angelo LS, Cardillo B, Cavallaro
teoglycan-mediated adhesion. J Biol Chem 1992; 267: 10133–10141. A. Shear stress modulates the proliferation rate, protein synthesis,
15 Mazur C, Tschopp JF, Faliakou EC et al. Selective alpha IIb and mitogenic activity of arterial smooth muscle cells. Surgery
beta 3 receptor blockage with peptide TP9201 prevents platelet 1993; 113: 691–699.
uptake on Dacron vascular grafts without significant effect on 28 Ziegler T, Alexander RW, Nerem RM. An endothelial cell-
bleeding time. J Lab Clin Med 1994; 124: 589–599. smooth muscle cell co-culture model for use in the investigation
16 Hay ED. Cell biology of extracellular matrix (2nd ed.). New of flow effects on vascular biology. Ann Biomed Eng 1995; 23:
York: Plenum Press, 1991. 216–225.
17 Scott M, Vesely I. Aortic valve cusp microstructure: the role of 29 Frank R, Adelmann Grill BC, Herrmann K et al. Transforming
elastin. Ann Thorac Surg 1995; 60: S391–S394. growth factor-beta controls cell–matrix interaction of micro-
18 Meredith JE Jr, Fazeli B, Schwartz MA. The extracellular vascular dermal endothelial cells by downregulation of integrin
matrix as a cell survival factor. Mol Biol Cell 1993; 4: 953–961. expression. J Invest Dermatol 1996; 106: 36–41.19 Thoumine O, Nerem RM, Girard PR. Oscillatory shear stress 30 Powell RJ, Cronenwett JL, Fillinger MF, Wagner RJ, Samp-and hydrostatic pressure modulate cell-matrix attachment pro- son LN. Endothelial cell modulation of smooth muscle cellteins in cultured endothelial cells. In Vitro Cell Dev Biol Anim morphology and organizational growth pattern. Ann Vasc Surg1995; 31: 45–54.
1996; 10: 4–10.20 Lee RT, Berditchevski F, Cheng GC, Hemler ME. Integrin-
mediated collagen matrix reorganization by cultured human
vascular smooth muscle cells. Circ Res 1995; 76: 209–214. Accepted 21 October 1999
Eur J Vasc Endovasc Surg Vol 19, April 2000
